Last Updated on July 16, 2024 by The Health Master
USFDA approval
Leading pharmaceutical company, Lupin, announced a significant development today with the tentative USFDA approval from the U.S. Food and Drug Administration (USFDA) for their generic equivalent of Sutab Tablets.
This approval pertains to Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, manufactured by Braintree Laboratories.
Potential Market
Lupin’s press release highlights their position as the “exclusive first-to-file” for this generic medication.
This prime position could translate to 180 days of marketing exclusivity, granting them a significant advantage in establishing their product within the US market.
Lupin’s Nagpur facility in India will be responsible for manufacturing these tablets.
Treatment Application
The approved Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets are specifically indicated for colon cleansing in adult patients undergoing colonoscopy procedures.
Colonoscopy is a vital diagnostic tool used to examine the inner lining of the colon for abnormalities such as polyps or cancer.
Proper bowel cleansing is crucial for ensuring a clear view during the procedure, leading to a more accurate diagnosis.
According to IQVIA MAT data for May 2024, the brand name equivalent, Sutab Tablets, boasted an estimated annual US market value of $148 million.
This sizeable market size underscores the potential commercial success of Lupin’s generic alternative.
Key Takeaways:
- Lupin receives tentative USFDA approval for their generic colonoscopy prep medication.
- Potential 180-day market exclusivity strengthens their position.
- The tablets target adult patients undergoing colonoscopy procedures.
- The generic version addresses a substantial US market for colon cleansing medications.
Disclaimer: This article is for informational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional before starting any new medication.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for the drug for the treatment of Migraine
USFDA approval granted for this chronic heart failure treatment drug
USFDA approval granted for generic Bromfenac Ophthalmic Solution
USFDA approval granted for this BP lowering drug
USFDA Tentative Approval granted for Bosutinib Tablets
USFDA approval granted for this Generic Olopatadine Eye Drops
USFDA issues positive EIR to Lupin Limited at Gujarat
Drug Rules to include excipient details in drug labels
USFDA approval granted for the drug for the treatment of Migraine
USFDA grants VAI classification to Cipla at Maharashtra
Stricter Regulations on Schedule G Drug Ads in India
Gist of the draft notification: Compounding of Offences under the Drugs and Cosmetics Act
Govt Considers Price Control on Nutraceuticals in India
Maharashtra FDA conducts raids at three different locations in Vasai
Telangana DCA seizes illegally stocked and overpriced medicines
USFDA approval granted for this chronic heart failure treatment drug
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
